← Leaderboards
Daniel T Monaghan
University Of Nebraska Medical Center
$4,790,397
Attributed
$6,345,172
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $391.2K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,345,172 · 5
By mechanism
R01$4,562,881 · 2
T32$1,324,022 · 1
P01$449,796 · 1
P41$8,473 · 1
Top collaborators
- Howard Eliot Gendelman9 shared
- David Edward Jane5 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- David Edward Jane$892,764
- Minglei Guo$7,203,802
- Udaykumar Ranga$1,296,777
- Guoku Hu$2,353,332
Others in their field
Top investigators on “Glutamates”
- Merit E Cudkowicz · Massachusetts General Hospital$40,827,833
- Alan G. Barbour · University Of California Irvine$39,660,285
- Scott W Woods · Yale University$33,212,495
- Paul F Worley · Johns Hopkins University$32,678,609
- Richard L Huganir · Johns Hopkins University$30,324,803
- John M Kane · Long Island Jewish Medical Center$28,729,148
Research focus
GlutamatesXenopus OocyteNmda ReceptorsN-Methyl-D-Aspartate ReceptorsSynapsesBinding SitesSchizophreniaSiteLigand BindingPoint MutationN-MethylaspartateReceptorPositioning AttributeNeuroimmunologyDrug DesignPainEpilepsyDesignAmino AcidsLocationAffinityLeadMolecular ModelingPattern
Grant awards (30)
Neuroimmunology of Disease Training Program$215,594
T32 · FY2025 · NS · contact PI
Neuroimmunology of Disease Training Program$60,566
T32 · FY2024 · NS · contact PI
Neuroimmunology of Disease Training Program$213,872
T32 · FY2023 · NS · contact PI
Neuroimmunology of Disease Training Program$1,836
T32 · FY2023 · NS · contact PI
Neuroimmunology of Disease Training Program$85,531
T32 · FY2022 · NS
Neuroimmunology of Disease Training Program$189,948
T32 · FY2021 · NS
Neuroimmunology of Disease Training Program$187,718
T32 · FY2020 · NS
Neuroimmunology of Disease Training Program$185,541
T32 · FY2019 · NS
Neuroimmunology of Disease Training Program$183,416
T32 · FY2018 · NS
Development and Pharmacology of Positive Allosteric Modulators of NMDA Receptors$357,526
R01 · FY2017 · MH · contact PI
Development and Pharmacology of Positive Allosteric Modulators of NMDA Receptors$357,526
R01 · FY2016 · MH · contact PI
Development and Pharmacology of Positive Allosteric Modulators of NMDA Receptors$357,526
R01 · FY2015 · MH · contact PI
Development and Pharmacology of Positive Allosteric Modulators of NMDA Receptors$321,774
R01 · FY2014 · MH · contact PI
Development and Pharmacology of Positive Allosteric Modulators of NMDA Receptors$391,176
R01 · FY2013 · MH · contact PI
Cleft binding NMDA Receptor Subtype Antagonists$269,874
R01 · FY2010 · MH · contact PI
Cleft binding NMDA Receptor Subtype Antagonists$269,874
R01 · FY2009 · MH · contact PI
Cleft binding NMDA Receptor Subtype Antagonists$269,874
R01 · FY2008 · MH · contact PI
NMDA RECEPTOR SIGNALING PATHWAYS IN BRAIN$8,473
P41 · FY2008 · RR · contact PI
Cleft binding NMDA Receptor Subtype Antagonists$281,624
R01 · FY2007 · MH · contact PI
Homocysteine and NMDA receptor in cardiac neural crest development$245,532
P01 · FY2005 · HL
CLEFT-BINDING NMDA RECEPTOR SUBTYPE ANTAGONISTS$251,700
R01 · FY2004 · MH
CLEFT-BINDING NMDA RECEPTOR SUBTYPE ANTAGONISTS$251,700
R01 · FY2003 · MH
CLEFT-BINDING NMDA RECEPTOR SUBTYPE ANTAGONISTS$279,194
R01 · FY2002 · MH
GROWTH FACTOR SIGNAL TRANSDUCTION AND NEUROTRANSMISSION$209,118
R01 · FY2002 · NS
Homocysteine and NMDA receptor in cardiac neural crest development$204,264
P01 · FY2002 · HL
Homocysteine and NMDA receptor in cardiac neural crest development$0
P01 · FY2002 · HL
CLEFT-BINDING NMDA RECEPTOR SUBTYPE ANTAGONISTS$291,500
R01 · FY2001 · MH
GROWTH FACTOR SIGNAL TRANSDUCTION AND NEUROTRANSMISSION$204,241
R01 · FY2001 · NS
Homocysteine and NMDA receptor in cardiac neural crest development$0
P01 · FY2001 · HL
GROWTH FACTOR SIGNAL TRANSDUCTION AND NEUROTRANSMISSION$198,654
R01 · FY2000 · NS